Synthesis of a 11C-Isotopologue of the B-Raf-Selective Inhibitor Encorafenib Using In-Loop [11C]CO2 Fixation-Reference-Cited by-同舟云学术

Synthesis of a 11C-Isotopologue of the B-Raf-Selective Inhibitor Encorafenib Using In-Loop [11C]CO2 Fixation

Published:2020-08-16 Issue:33 Volume:5 Page:20960-20966
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Dornan Mark H.¹²^ORCID,Petrenyov Daniil²^ORCID,Simard José-Mathieu²,Boudjemeline Mehdi²,Mititelu Roxana³,DaSilva Jean N.²^ORCID,Belanger Anthony P.¹

Affiliation:

1. Department of Imaging, Dana-Farber Cancer Institute & Department of Radiology, Harvard Medical School, Boston, Massachusetts 02115, United States

2. Laboratoire de Radiochimie et Cyclotron, Centre de Recherche du Centre Hospitalier de l’Université de Montréal & Département de Radiologie, radiooncologie et médecine nucléaire, Faculté de médecine, Université de Montréal, Montréal, Quebec H3T 1J4, Canada

3. Division of Dermatology, Department of Medicine, McGill University, Montreal, Quebec H4A 3J1, Canada

Funder

Friends of Dana-Farber Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.0c02419

Reference21 articles.

1. The global burden of melanoma: results from the Global Burden of Disease Study 2015

2. The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe

3. Cancer statistics, 2019

4. Targeting Oncogenic BRAF: Past, Present, and Future

5. Disease progression and patient survival are significantly influenced by BRAF protein expression in primary melanoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serine/threonine-protein kinase B-Raf inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

2. Biological functions and research progress of eIF4E;Frontiers in Oncology;2023-08-03

3. Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy;Science Advances;2022-04-29